Cancer resistant anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Tumor Cells, Cultured Cell Line HCT116 Cells MCF-7 Cells HT29 Cells Neoplastic Stem Cells HeLa Cells Cells, Cultured Mitochondria Fibroblasts K562 Cells

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases41

Breast Neoplasms Radiation Injuries Neoplasms Colonic Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasms, Radiation-Induced Prostatic Neoplasms Radiation Injuries, Experimental Neoplasm Metastasis Stomach Neoplasms Pancreatic Neoplasms Radiation Pneumonitis Neoplasm Invasiveness Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Carcinoma Adenocarcinoma Uterine Cervical Neoplasms Neoplasms, Experimental Head and Neck Neoplasms Colorectal Neoplasms Neoplasm Recurrence, Local Disease Progression Cell Transformation, Neoplastic Urinary Bladder Neoplasms Genetic Predisposition to Disease Brain Neoplasms Liver Neoplasms Neovascularization, Pathologic Rectal Neoplasms Melanoma Skin Neoplasms Acute Radiation Syndrome Leukemia P388 Disease Models, Animal Bone Neoplasms Esophageal Neoplasms Mammary Neoplasms, Experimental Carcinoma, Small Cell Endometrial Neoplasms

Chemicals and Drugs73

Taxoids Antineoplastic Agents Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin Antibiotics, Antineoplastic Paclitaxel Neoplasm Proteins Drug Carriers Radiation-Sensitizing Agents Camptothecin Tumor Suppressor Protein p53 Fluorouracil Etoposide P-Glycoprotein RNA, Messenger Ellipticines Enzyme Inhibitors RNA, Small Interfering Antimetabolites, Antineoplastic DNA, Neoplasm Cancer Vaccines Proto-Oncogene Proteins c-bcl-2 Prodrugs Organoplatinum Compounds Anticarcinogenic Agents Tumor Markers, Biological Plant Extracts Caspases DNA-Binding Proteins DNA DNA Topoisomerases, Type II Caspase 3 Radiation-Protective Agents Platinum Daunorubicin Antibodies, Monoclonal Topoisomerase I Inhibitors Deoxycytidine Receptor, erbB-2 Protein Kinase Inhibitors Antineoplastic Agents, Alkylating Anti-Bacterial Agents Mitomycin Tumor Suppressor Proteins Antigens, Neoplasm Vinblastine Protein-Serine-Threonine Kinases Receptor, Epidermal Growth Factor Mitoxantrone Receptors, Estrogen DNA Adducts Nanocapsules Tamoxifen Proto-Oncogene Proteins c-akt Multidrug Resistance-Associated Proteins Prostate-Specific Antigen ATP-Binding Cassette Transporters Nuclear Proteins Reactive Oxygen Species Cobalt Radioisotopes Proto-Oncogene Proteins Cell Cycle Proteins Quinazolines Bleomycin Indoles Topoisomerase II Inhibitors Histone Deacetylase Inhibitors Poly(ADP-ribose) Polymerases Drugs, Investigational Tubulin Modulators RNA, Neoplasm Transcription Factors

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Radiation Monitoring Xenograft Model Antitumor Assays Early Detection of Cancer Drug Delivery Systems Combined Modality Therapy Radiotherapy Antineoplastic Combined Chemotherapy Protocols Drug Carriers Radiation Injuries, Experimental Inhibitory Concentration 50 Neoplasm Transplantation Blotting, Western Radiotherapy Dosage Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Transplantation, Heterologous Radiometry Molecular Targeted Therapy Drug Design Gene Expression Profiling Survival Rate Models, Biological Prognosis Retrospective Studies Flow Cytometry Tumor Burden Transfection Neoplasms, Experimental Clinical Trials as Topic Follow-Up Studies Treatment Outcome Drug Evaluation, Preclinical Neoplasm Staging Disease-Free Survival Prospective Studies Risk Radiotherapy, Adjuvant Risk Assessment Drug Discovery Oligonucleotide Array Sequence Analysis Tumor Stem Cell Assay Polymerase Chain Reaction Chemotherapy, Adjuvant Sensitivity and Specificity Nanocapsules Dose Fractionation Registries Microbial Sensitivity Tests Reproducibility of Results Disease Models, Animal Drug Administration Schedule Risk Factors Gene Knockdown Techniques Mammary Neoplasms, Experimental Clinical Trials, Phase I as Topic Tomography, X-Ray Computed Radiotherapy Planning, Computer-Assisted Kaplan-Meier Estimate Radiation Hybrid Mapping Radiotherapy, Conformal Odds Ratio Immunohistochemistry

Phenomena and Processes58

Drug Resistance, Neoplasm Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Apoptosis Cell Survival Gene Expression Regulation, Neoplastic Cell Proliferation DNA Damage Dose-Response Relationship, Drug Gamma Rays Drug Resistance, Multiple Drug Resistance Mutation Cosmic Radiation Cell Cycle Drug Synergism Inhibitory Concentration 50 Ultraviolet Rays Cell Division Time Factors Background Radiation DNA Repair Signal Transduction Down-Regulation Transfection Base Sequence Molecular Structure Radiation Effects Cell Death Genetic Predisposition to Disease Phosphorylation Up-Regulation Risk RNA Interference Cell Growth Processes Phenotype Gene Expression Sensitivity and Specificity X-Rays Genes, p53 DNA Adducts Promoter Regions, Genetic Enzyme Activation Structure-Activity Relationship Cell Movement Drug Resistance, Microbial Genotype Gene Silencing Protein Binding DNA Methylation Amino Acid Sequence Genes, MDR Polymorphism, Genetic Kinetics Odds Ratio

Disciplines and Occupations7

Radiation Oncology Drug Design Nanomedicine Medical Oncology Drug Discovery Radiobiology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Information Science7

Molecular Sequence Data Survival Rate Base Sequence Registries Amino Acid Sequence Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal

Named Groups1

Health Care30

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Ultraviolet Rays Survival Analysis National Cancer Institute (U.S.)Survival Rate Retrospective Studies Radiation Effects Clinical Trials as Topic Follow-Up Studies Treatment Outcome Disease-Free Survival Prospective Studies Risk Risk Assessment Sensitivity and Specificity Acute Radiation Syndrome Registries Age Factors Reproducibility of Results Radioactive Hazard Release Risk Factors Clinical Trials, Phase I as Topic Kaplan-Meier Estimate Odds Ratio

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Drug Resistance, Neoplasm Taxoids Breast Neoplasms Antineoplastic Agents Radiation Dosage Radiation, Ionizing Radiation Injuries Cell Line, Tumor Dose-Response Relationship, Radiation Radiation Tolerance Neoplasms Drug Screening Assays, Antitumor Radiation Radiation Protection Radiation Monitoring Apoptosis Cell Survival Mice, Nude Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin Xenograft Model Antitumor Assays Tumor Cells, Cultured Early Detection of Cancer Colonic Neoplasms Antibiotics, Antineoplastic Radiation Oncology Gene Expression Regulation, Neoplastic Lung Neoplasms Ovarian Neoplasms Drug Delivery Systems Cell Proliferation Neoplasms, Radiation-Induced Prostatic Neoplasms Combined Modality Therapy DNA Damage Radiotherapy Dose-Response Relationship, Drug Paclitaxel Gamma Rays Neoplasm Proteins Drug Resistance, Multiple Drug Resistance Mutation Cosmic Radiation Cell Cycle Antineoplastic Combined Chemotherapy Protocols Drug Carriers Radiation Injuries, Experimental Radiation-Sensitizing Agents Neoplasm Metastasis Stomach Neoplasms Drug Synergism Pancreatic Neoplasms Camptothecin Radiation Pneumonitis Tumor Suppressor Protein p53 Inhibitory Concentration 50 Fluorouracil Neoplasm Transplantation Etoposide P-Glycoprotein Neoplasm Invasiveness Blotting, Western Radiotherapy Dosage Ultraviolet Rays RNA, Messenger Carcinoma, Squamous Cell Ellipticines Cell Division Reverse Transcriptase Polymerase Chain Reaction Time Factors Enzyme Inhibitors RNA, Small Interfering Survival Analysis Background Radiation Transplantation, Heterologous Radiometry Molecular Sequence Data Carcinoma, Non-Small-Cell Lung DNA Repair Antimetabolites, Antineoplastic Carcinoma Signal Transduction National Cancer Institute (U.S.)Molecular Targeted Therapy Drug Design DNA, Neoplasm Gene Expression Profiling Adenocarcinoma Uterine Cervical Neoplasms Cancer Vaccines Cell Line Survival Rate Models, Biological Prognosis Retrospective Studies Down-Regulation Flow Cytometry Tumor Burden

No FAQ available that match "cancer resistant anticancer drugs or radiation"